Angiogenesis is a complicated pathological process and plays an important role in modulating
tumor development.
Flavonoids, sharing the basic functional group with
estrogen, have been utilized as chemopreventive agents to inhibit endothelial cell angiogenesis and also suppress
tumor cell proliferation.
Ononin, also referred to as formononetin-7-O-β-d-glucoside, is one of the bioactive chemicals found within many functional food or plants. The anticancer functions of
ononin have been reported both in vitro and in vivo. However, the anti-angiogenetic properties of
ononin have not been reported. The possible efficacies of
ononin against angiogenesis was verified in cultured endothelial cells.
Ononin suppressed
vascular endothelial growth factor (
VEGF)-induced HUVEC migration, invasion. and tube formation activity after 48 h. The apoptosis rate and specific markers, i.e., Bax/Bc-2 ratio, cleaved
caspase 3/9 (Cl-
caspase 3/9), and
cytochrome c (Cyto c), were enhanced in the
ononin-treated group. On the other hand, the
protein expressions levels of
hypoxia-inducible factor 1α (HIF-1α),
mitogen-activated protein kinase kinase (
MEK)/
extracellular signal-regulated kinase (ERK), and
vascular endothelial growth factor receptor 2 (VEGFR2) were restricted after
ononin treatment for 2 days in
VEGF-pretreated endothelial cells. In summary,
ononin acts as a candidate for angiogenetic-related disease prevention and treatment.